Sight Sciences, Inc. SGHT Accrued compensation and employee benefits

Accrued compensation and employee benefits at other companies

Schering-PloughSGP

——

Tarsus Pharmaceuticals, Inc.TARS

——

Other financials

Income statement

See full

Revenue$19.7M+12.5%

Gross profit$17.0M+12.5%

Operating income-$12.4M+10.4%

Net income-$13.0M+8.3%

EPS (diluted)-$0.24+14.3%

Balance sheet

See full

Cash & equivalents$85.0M-21.9%

Total debt$40.9M+1.1%

Total equity$53.9M-30.6%

Total assets$109.7M-15.4%

Cash flow

See full

Operating cash flow-$7.0M+39.4%

CapEx$60.0K—

Free cash flow-$7.1M+38.9%

Valuation

See full

Market cap$294.9M+35.0%

Enterprise value$250.83M+59.0%

P/S3.7×+0.8×

Profitability

See full

Gross margin86.2%+0.5pp

Operating margin-44.8%-10.2pp

Net margin-46.8%-9.6pp

FCF margin-31.9%+0.2pp

Returns & leverage

See full

Return on equity-56.6%+4.3pp

Debt / equity0.8×+0.2×

Current ratio5.9×-4.6×

Where this comes from

Reported directly by Sight Sciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities.

The official record: Sight Sciences, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sight Sciences, Inc.'s accrued compensation and employee benefits.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Sight Sciences, Inc.'s accrued compensation and employee benefits?: Sight Sciences, Inc. (SGHT) reported accrued compensation and employee benefits of -$2.38M in Q1 2026.
How has Sight Sciences, Inc.'s accrued compensation and employee benefits changed year-over-year?: Sight Sciences, Inc.'s accrued compensation and employee benefits increased by 47.7% year-over-year, from -$4.55M to -$2.38M.